| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LANNETT CO INC | Director | Common stock | 93,259 | $437,385 | $4.69 | 14 Sep 2022 | Direct |
| Arbutus Biopharma Corp | Director | Stock Option (Right to Buy) | 67,000 | $188,270 | $2.81 | 23 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 23 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 16:10 |
| ABUS | Arbutus Biopharma Corp | 12 Jul 2023 | 1 | $0 | 4 | Director | 13 Jul 2023, 16:13 |
| ABUS | Arbutus Biopharma Corp | 12 Jul 2023 | 0 | $0 | 3 | Director | 13 Jul 2023, 16:11 |
| /report/000120919122050088-rewolinski-melissa-2022-09-14 | LANNETT CO INC | 14 Sep 2022 | 1 | +$15,268 | 4 | Director | 15 Sep 2022, 16:52 |
| /report/000120919121055664-rewolinski-melissa-2021-09-09 | LANNETT CO INC | 09 Sep 2021 | 1 | -$80,581 | 4 | Director | 13 Sep 2021, 16:09 |
| /report/000120919121054555-rewolinski-melissa-2021-08-31 | LANNETT CO INC | 31 Aug 2021 | 1 | $0 | 4 | Director | 02 Sep 2021, 18:31 |
| /report/000120919121039505-rewolinski-melissa-2020-09-03 | LANNETT CO INC | 03 Sep 2020 | 1 | -$75,278 | 4 | Director | 10 Jun 2021, 16:43 |